(TGTX) TG Therapeutics - Performance 171.9% in 12m
Compare TGTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
45.68%
#12 in Group
Rel. Strength
98.54%
#114 in Universe
Total Return 12m
171.87%
#6 in Group
Total Return 5y
311.51%
#8 in Group
P/E 252
100th Percentile in Group
P/E Forward 27.2
71th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -0.69%
70th Percentile in Group
12m Total Return: TGTX (171.9%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-4.65% | 17.9% | 229% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-0.86% | 32.9% | 221% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-1.23% | 27.5% | 43.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-0.3% | 16.4% | 70.8% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.03% | -0.49% | 38.3% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.85% | 21.5% | 13.9% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
-4.86% | 15.4% | 6.78% | 27 | 25 | 1 | 58.7% | 15% |
| ERF PA Eurofins Scientific SE |
0.82% | -17.5% | 16.4% | 23.9 | 12.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: TGTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TGTX
| Total Return (including Dividends) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 14.29% | -8.71% | -7.79% |
| 3 Months | 30.92% | -15.44% | -9.06% |
| 12 Months | 171.87% | -14.04% | 4.64% |
| 5 Years | 311.51% | -2.41% | 117.94% |
| Trend Score (consistency of price movement) | TGTX | XBI | S&P 500 |
| 1 Month | 32.9% | -62.6% | -5.5% |
| 3 Months | 79.5% | -73% | -61.9% |
| 12 Months | 94.6% | -8.4% | 82.8% |
| 5 Years | -15.9% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #18 | 25.2% | 24.0% |
| 3 Month | #11 | 54.8% | 44.0% |
| 12 Month | #5 | 216% | 160% |
| 5 Years | #9 | 322% | 88.8% |
FAQs
Does TGTX TG Therapeutics outperforms the market?
Yes,
over the last 12 months TGTX made 171.87%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.04%.
Over the last 3 months TGTX made 30.92%, while XBI made -15.44%.
Over the last 3 months TGTX made 30.92%, while XBI made -15.44%.
Performance Comparison TGTX vs Indeces and Sectors
TGTX vs. Indices TGTX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.22% | 22.1% | 82.2% | 167% |
| US NASDAQ 100 | QQQ | 4.29% | 23.5% | 83.4% | 169% |
| US Dow Jones Industrial 30 | DIA | 2.05% | 20.3% | 80.1% | 167% |
| German DAX 40 | DAX | 2.10% | 20.6% | 63.3% | 154% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.50% | 15.1% | 92.4% | 164% |
| Hongkong Hang Seng | HSI | -0.29% | 13.3% | 85.7% | 155% |
| India NIFTY 50 | INDA | -0.96% | 7.22% | 87.4% | 172% |
| Brasil Bovespa | EWZ | -2.14% | 5.22% | 83.0% | 183% |
TGTX vs. Sectors TGTX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.06% | 22.4% | 73.8% | 159% |
| Consumer Discretionary | XLY | 3.92% | 23.9% | 79.2% | 165% |
| Consumer Staples | XLP | -3.64% | 15.6% | 75.0% | 159% |
| Energy | XLE | 4.46% | 14.8% | 81.8% | 180% |
| Financial | XLF | 2.82% | 21.8% | 70.2% | 156% |
| Health Care | XLV | -0.87% | 18.2% | 82.0% | 171% |
| Industrial | XLI | 3.16% | 20.4% | 83.0% | 170% |
| Materials | XLB | 1.97% | 18.3% | 88.7% | 181% |
| Real Estate | XLRE | -0.67% | 19.9% | 82.5% | 162% |
| Technology | XLK | 5.56% | 24.9% | 89.4% | 177% |
| Utilities | XLU | -4.09% | 14.1% | 78.9% | 147% |
| Aerospace & Defense | XAR | 2.84% | 17.7% | 77.2% | 157% |
| Biotech | XBI | 6.50% | 23.0% | 96.4% | 186% |
| Homebuilder | XHB | 4.91% | 21.2% | 102% | 187% |
| Retail | XRT | 4.27% | 22.8% | 88.9% | 183% |